SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001140361-20-013613
Filing Date
2020-06-11
Accepted
2020-06-11 17:16:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A nt10012477x2_s3a.htm S-3/A 243951
2 logo_cidara.jpg GRAPHIC 55201
  Complete submission text file 0001140361-20-013613.txt   320926
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-238955 | Film No.: 20957976
SIC: 2836 Biological Products, (No Diagnostic Substances)